ASHPOfficial

ASHP sits down with Drs. Amie Blaszczyk, PharmD, BCGP, BCPS, FASCP, Associate Professor and Division Head-Geriatrics at Texas Tech University Health Sciences Center in Dallas, Texas and Dana Carroll PharmD., BCGP, BCPS, CDE, Clinical Professor at the Auburn University Harrison School of Pharmacy in Auburn, Alabama as they discuss geriatric practice considerations in the long term care and ambulatory care settings at this time. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Today on ASHPOfficial, we chat with Dr. Amanda Margolis, PharmD, MS, BCACP and Dr. Marina Maes, PharmD, BCPS, BCACP, assistant professors at the University of Wisconsin-Madison School of Pharmacy in the pharmacy practice division. Dr. Margolis and Dr. Maes dive into how they are adapting to this evolving situation and share key insights into what teaching and practice model looks during COVID-19.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join ASHP for a  discussion concerning the updates from the 2019 IDSA/ATS Community Acquired Pneumonia Guidelines published in October of 2019. These guidelines are an update to the previous 2007 guidelines with new information on outpatient and inpatient management, as well as topics the previous guidelines did not address, such as aspiration pneumonia and the use of corticosteroids.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Due to the COVID-19 pandemic, ambulatory care clinics have transitioned to telehealth services to allow for continued care of patients, while minimizing possible exposure to COVID-19.  This podcast will explore the implementation and expansion of telehealth pharmacy services in two different ambulatory care clinics in response to the COVID-19 pandemic.  Speakers will discuss the types of telehealth visits provided, the roadblocks encountered, lessons learned, and reimbursement.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Eric Maroyka sits down with Elaine Snow to discuss how her team amends the evidence table and works with ASHP to ensure that pharmacists are working with the most up to date information concerning patient care. Listen in as they explore  ASHP’s Assessment of Evidence for COVID-19 Related Treatments and how pharmacists can apply this information to their practice. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.